The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Helena Laboratories sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Data Insights Helena Laboratories Corp, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Helena Laboratories Corp (Helena) is a medical device company that provides clinical laboratory instruments. The company offers electrophoresis analyzers, densitometers, electrophoresis supplies, hemostasis instruments, spife replacement pumps, and immunology and protein diagnostic products. It offers column chromatography supplies, disposable laboratory plasticware and test kits for fecal occult blood. Helena offers automated gel electrophoresis systems for serum proteins, immunofixation, and cholesterol and hemoglobin analysis. The company caters to medical centers, hospitals, reference laboratories and private doctor’s laboratories. It markets its products across Algeria, Argentina, Austria, Bahrain, Bangladesh, Belgium, Brazil, China, Colombia and Costa Rica. Helena is headquartered in Beaumont, Texas, the US Key subsidiaries of Helena Laboratories include Labcon North America, Helena Laboratories (Australia) Pty., Helena BioSciences Europe and Kabushiki Kaisha Helena Kenkyujyo.

The key metrics of Helena Laboratories related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As Helena Laboratories is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Helena Laboratories.

For a detailed understanding of the performance of Helena Laboratories, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.